A Health Economic Study Evaluating the Brain Sentinel® GTC Seizure Detection and Information Systems Impact on Epilepsy and Healthcare Utilization

B

Brain Sentinel

Status

Terminated

Conditions

Epilepsy

Treatments

Device: Brain Sentinel Seizure Detection and Information System

Study type

Observational

Funder types

Other

Identifiers

NCT02752373
HE-1.5-03.2016

Details and patient eligibility

About

This is an open label prospective study of the impact on healthcare utilization of a surface Electromyography (sEMG) based seizure detection system for detecting Generalized Tonic-Clonic (GTC) Seizures.

Full description

The Brain Sentinel® GTC Seizure Detection and Information System is an ambulatory system designed to continuously monitor and perform real-time analysis of surface electromyography (sEMG) data to detect GTC seizures and to provide an alarm to alert caregivers within 30 seconds of bilateral, appendicular, tonic extension that a seizure is occurring. The System is for recording and storing sEMG data, which is subsequently reviewed by a trained healthcare professional in the outpatient clinical setting. The Brain Sentinel® GTC Seizure Detection and Information System is intended for real time monitoring of pediatric and adult patients who have an arm circumference ranging from at least 16 cm to no greater than 51 cm at the biceps. It may be used in the home or healthcare facilities for real-time monitoring during the day, night, or for continuous monitoring, including during the titration of, or the withdrawal from anti-epileptic drugs.

Enrollment

5 patients

Sex

All

Ages

2 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subject has a history of GTC seizures, either primary GTC or partial onset seizures with secondary generalization
  • Male or female greater than 2 years of age
  • Has an upper arm circumference which is adequate for proper fit of the EMG monitor (at least 16-51 cm)
  • Be able to tolerate wearing the device on the upper arm
  • Can understand and sign written informed consent, or will have a parent or a legally authorized representative (LAR) who can do so, prior to the performance of any study assessments
  • Subject and/or Primary Caregiver must be competent to follow all study procedures.
  • Is able to read, speak and understand English
  • At least 2 or more Emergency Department visits in the previous 12 months for seizure related care

Exclusion criteria

  • The subject is homeless or in a home without a power supply.
  • The subject is allergic to adhesives or any component of the electrode patch assembly.
  • The subject self-reports that she is pregnant or planning to become pregnant while using the device.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems